The DOI matches its Crossref record; 50 of the 55 references it cites were found in a registry or an index.
Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers
Abstract
Objectives Ovarian carcinoma cells form multicellular aggregates, or spheroids, in the peritoneal cavity of patients with advanced disease. The current paradigm that ascites spheroids are non-adhesive leaves their contribution to ovarian carcinoma dissemination undefined. Here, spheroids obtained from ovarian carcinoma patients' ascites were characterized for their ability to adhere to molecules encountered in the peritoneal cavity, with the goal of establishing their potential to contribute to ovarian cancer spread.Methods Spheroids were recovered from the ascites fluid of 11 patients with stage III or stage IV ovarian carcinoma. Adhesion assays to extracellular matrix (ECM) proteins and human mesothelial cell monolayers were performed for each of the ascites spheroid samples. Subsequently, inhibition assays were performed to identify the cell receptors involved.Results Most ascites samples adhered moderately to fibronectin and type I collagen, with reduced adhesion to type IV collagen and laminin. Monoclonal antibodies against the beta1 integrin subunit partially inhibited this adhesion. Ascites spheroids also adhered to hyaluronan. Additionally, spheroids adhered to live, but not fixed, human mesothelial cell monolayers, and this adhesion was partially mediated by beta1 integrins.Conclusions The cellular content of the ascites fluid has often been considered non-adhesive, but our findings are the first to suggest that patient-derived ascites spheroids can adhere to mesothelial extracellular matrix via beta1 integrins, indicating that spheroids should not be ignored in the dissemination of ovarian cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“OVCAR-5 spheroids plated on a collagen-I coating, were observed to readily disaggregate with increasing collagen concentration, compared to laminin or collagen-IV coatings, thus highlighting its properties as a promoter of cancer cell adhesion and invasion (Burleson et al., 2004).”
From Three-dimensional modelling of ovarian cancer: from cell lines to organoids for discovery and personalized medicine (2022) · cites this paper as Burleson et al., 2004
Citations
Cites
Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., & Thun, M. J. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.1.5 · Cited by 3,275
Cell and environment interactions in tumor microregions: the multicell spheroid model.
Sutherland, R. M. (1988) · Science · doi:10.1126/science.2451290 · Cited by 1,803
CD44 and Its Interaction with Extracellular Matrix
Lesley, J., Hyman, R., & Kincade, P. W. (1993) · Advances in immunology · doi:10.1016/s0065-2776(08)60537-4 · Cited by 1,059
Cannistra, S. (1993) · New England Journal of Medicine · doi:10.1056/nejmra041842 · Cited by 957
Growth of Multicell Spheroids in Tissue Culture as a Model of Nodular Carcinomas 2
Sutherland, R. M., McCredie, J. A., & Inch, W. R. (1971) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/46.1.113 · Cited by 585
Hyaluronan-binding Proteins: Tying Up the Giant
Day, A. J., & Prestwich, G. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100036200 · Cited by 567
Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility
Hardwick, C., Hoare, K., Owens, R. J., Hohn, H.-P., Höök, M., Moore, D. H., Cripps, V., Austen, L., Nance, D., & Turley, E. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.117.6.1343 · Cited by 403
Isolation, culture and characterization of human peritoneal mesothelial cells
Stylianou, E., Jenner, L. A., Davies, M., Coles, G. A., & Williams, J. D. (1990) · Kidney International · doi:10.1038/ki.1990.150 · Cited by 389
Cannistra, S. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311183292108 · Cited by 294
Effects of intercellular contact on repair of radiation damage
Durand, R. E., & Sutherland, R. M. (1972) · Experimental Cell Research · doi:10.1016/0014-4827(72)90265-0 · Cited by 287
Flagged first, then by citations
5 of the 55 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–271 of 271
Bochner, F., Fellus-Alyagor, L., Ketter, D., Golani, O., Biton, I. E., & Neeman, M. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0878-7 · Cited by 9
Ziske, M. A., Pettee, K. M., Khaing, M., Rubinic, K. A., & Eisenmann, K. M. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.049 · Cited by 8
Targeting locoregional peritoneal dissemination in ovarian cancer
Janczar, S., Graham, J., Paige, A., & Gabra, H. (2009) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.4.2.133 · Cited by 8
Multiscale mechanisms driving tissue rupture by invading cells
Wu, S. K., Sun, F., Ho, C. Z., Lou, Y., Huang, C. B.-X., Nai, M. H., Xiao, J., Shagirov, M., Chin, J. F. L., Lim, D. G. S., et al. (2026) · Developmental Cell · doi:10.1016/j.devcel.2026.01.016 · Cited by 7
Rheological transition driven by matrix makes cancer spheroids resilient under confinement
Dutt, T., Langthasa, J., Monica, U., Mishra, S., Bothra, S., Vidhipriya, K., Vadaparty, A., Sen, P., & Bhat, R. (2025) · Life Science Alliance · doi:10.26508/lsa.202402601 · Cited by 6
Genomic markers of ovarian adenocarcinoma and its relevancy to the effectiveness of chemotherapy
Englert-Golon, M., Burchardt, B., Budny, B., Dębicki, S., Majchrzycka, B., Wrotkowska, E., Jasiński, P., Ziemnicka, K., Słopień, R., Ruchała, M., et al. (2017) · Oncology Letters · doi:10.3892/ol.2017.6590 · Cited by 7
Chemoresistance of Lung Cancer Cells: 2D and 3D In Vitro Models for Anticancer Drug Screening
Kaushik, V., Yakisich, J. S., Kulkarni, Y., Azad, N., & Iyer, A. K. V. (2018) · InTech eBooks · doi:10.5772/intechopen.78946 · Cited by 7
Tomas, E. J., Valdés, Y. R., Davis, J., Kolendowski, B., Buensuceso, A. V., DiMattia, G. E., & Shepherd, T. G. (2025) · Cells · doi:10.3390/cells14020133 · Cited by 7
Deciphering the Therapeutic Applications of Nanomedicine in Ovarian Cancer Therapy: An Overview
Mathur, P., Bhatt, S., Kumar, S., Kamboj, S., Kamboj, R., Rana, A., Kumar, H., & Verma, R. (2023) · Current Drug Delivery · doi:10.2174/0115672018253815230922070558 · Cited by 6
Xie, X., Long, L., Wang, H., Zheng, Y., & Liu, S. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.11.018 · Cited by 6
Wesley, T., Escalona, R. M., Kannourakis, G., & Ahmed, N. (2024) · Cancers · doi:10.3390/cancers16234087 · Cited by 5
Screening of integrins localized on the surface of human epidermal melanocytes
Kim, S.-J., Kim, M. S., Park, H. J., Lee, H., Yun, J. I., Lim, H. W., & Lee, S. T. (2020) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-020-00471-4 · Cited by 5
Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
Bilandzic, M., & Stenvers, K. L. (2014) · Journal of Visualized Experiments · doi:10.3791/51655-v · Cited by 5
Martínez, A., Buckley, M., Scalise, C. B., Wang, D., Katre, A. A., Birrer, M. J., Berry, J. L., & Arend, R. C. (2021) · Journal of Tissue Engineering · doi:10.1177/20417314211055015 · Cited by 5
DNA Repair: ERCC1, Nucleotide Excision Repair, and Platinum Resistance
Reed, E., Larkins, T. L., Chau, C. H., & Figg, W. D. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-9135-4_18 · Cited by 5
Durotaxis and extracellular matrix degradation promote the clustering of cancer cells
Potomkin, M., Kim, O. V., Klymenko, Y., Alber, M., & Aranson, I. S. (2025) · iScience · doi:10.1016/j.isci.2025.111883 · Cited by 4
Immunotherapy advancements in high-grade serous ovarian cancer: From promise to practice
Heidinger, M., Caruso, G., Coelho, R., Stiegeler, N., Petousis, S., Kacperczyk-Bartnik, J. P., Oseledchyk, A., Jacob, F., Kurzeder, C., Heinzelmann-Schwarz, V. A., et al. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105312 · Cited by 4
Reversible downregulation of MYC in a spheroid model of metastatic epithelial ovarian cancer
Buensuceso, A. V., Borrelli, M. J., Valdés, Y. R., & Shepherd, T. G. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00850-z · Cited by 5
Thibault, B., Thole, A., D’Angelo, R., Basset, C., & Guillermet‐Guibert, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-90714-9 · Cited by 4
Hudson, L. G., & Stack, M. S. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6615-5_24 · Cited by 4
Tumour-on-Chip Models for the Study of Ovarian Cancer: Current Challenges and Future Prospects
Lim, S. Y., Aboelnasr, L. S., & El-Bahrawy, M. A. (2025) · Cancers · doi:10.3390/cancers17193239 · Cited by 3
Role of AMIGO2 in cancer progression: Novel insights (Review)
Tian, Z., Zhou, D., Jiang, R., & Zhou, B. (2024) · Oncology Letters · doi:10.3892/ol.2024.14567 · Cited by 3
Toward an Integrative Analysis of the Tumor Microenvironment in Ovarian Epithelial Carcinoma
Serio, R. N. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0092-5 · Cited by 3
Integrins in Ovarian Cancer: Survival Pathways, Malignant Ascites and Targeted Photochemistry
Ruhi, M. K., Rickard, B. P., Polacheck, W. J., & Rizvi, I. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106725 · Cited by 2
Adult Stem Cell Niches — Stem Cells in the Female Reproductive System
Kessler, M., Zietlow, R., & Meyer, T. F. (2014) · InTech eBooks · doi:10.5772/58842 · Cited by 4
Ovarian Cancer Research in the Post Genomic Era — Challenges and Opportunities
Goyeneche, A. A., & Telleria, C. M. (2016) · InTech eBooks · doi:10.5772/60600 · Cited by 3
Challenges in Experimental Modeling of Ovarian Cancerogenesis
Petrik, J. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-547-7_28 · Cited by 3
CAMKKβ supports growth and viability of epithelial ovarian cancer in vitro and in vivo
Borrelli, M. J., Buensuceso, A. V., Valdés, Y. R., Johnston, T. P. A., Haagsma, J., & Shepherd, T. G. (2025) · Scientific Reports · doi:10.1038/s41598-025-11584-9 · Cited by 2
Distinct Chemical Cues Reprogram Cellular and Multicellular Phenotypes in Ovarian Cancer Spheroids
Sreepadmanabh, M., Ganesh, M., Langthasa, J., Bhat, R., & Bhattacharjee, T. (2025) · Small · doi:10.1002/smll.202506120 · Cited by 2
Solitary ovarian cancer cells in the peritoneum: What happens below the surface?
Vos, L. M. C., van Driel, W. J., Sonke, G. S., van Baal, J. O. A. M., de Vijver, K. K. V., Noorden, C. J. F. V., & Lok, C. A. R. (2022) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2022.100049 · Cited by 2
Malek, A. V., Schäfer, R., & Tchernitsa, O. I. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.10.005 · Cited by 2
Targeting Leader Cells in Ovarian Cancer as an Effective Therapeutic Option
Karimnia, N., Ho, G., Stephens, A. N., & Bilandzic, M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98689 · Cited by 2
Recent Advances, New Perspectives and Applications in the Treatment of Ovarian Cancer
Friedrich, M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100847 · Cited by 3
Peng, J., Yang, X., Li, X., Gao, H., Liu, N., & Guo, X. Q. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1634946 · Cited by 2
Hotwiring integrin endocytosis acutely modulates cell interactionsPreprint
Kamboj, S., Boché, A., Moret, A., Wang, Z., Aimé, C., Agniel, R., Leroy‐Dudal, J., Carreiras, F., Gallet, O., Royle, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.24.600360 · Cited by 2
Tumor Microenvironment of Epithelial Ovarian Cancer
Perkins, R. S., Choi, W.-Y., & Zhang, M. S. J. A. W. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1013212 · Cited by 3
Rozier, M. C. J., Adjei, D. N., Radtke, R. A., & Chadee, D. N. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2026.120106 · Cited by 1
Ovarian/Primary Peritoneal Carcinoma
Davidson, B. (2011) · Springer eBooks · doi:10.1007/978-0-85729-697-9_3 · Cited by 1
Prystupa, T. (2023) · American Journal of BioMedicine · doi:10.18081/2333-5106/2023.11/158 · Cited by 1
Risk factors for peritoneal dissemination of ovarian cancer
Turanjanin, D., Stipic, N., Stanulović, N., & Gardić, N. (2023) · Medicinski pregled · doi:10.2298/mpns2312331t · Cited by 1
A method for dissociation of oral cancer cell spheroids generated by magnetic 3D bioprinting
Fernandes, N. A. R., Nascimento, C. R., Coletta, R. D., & Rossa, C. (2025) · Cytotechnology · doi:10.1007/s10616-025-00776-w · Cited by 1
Langthasa, J., Sarkar, P., & Bhat, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817996-3.00016-5 · Cited by 1
Haria, D. (2014) · Digital Commons-TMC (Texas Medical Center)
Imaging CXCL12-CXCR4 Signaling and Inhibition in Ovarian Cancer
Luker, G. D. (2012) · Defense Technical Information Center (DTIC) · doi:10.21236/ada566816
Homeobox Genes and Their Functional Significance in Ovarian Tumorigenesis
Trinh, B. Q., & Naor, H. (2012) · InTech eBooks · doi:10.5772/27549
Zhou, L., Graves, M. L., MacDonald, G., Cipollone, J., Mueller, C. R., & Roskelley, C. D. (2013)
Mechanism of tissue transglutaminase upregulation and its role in ovarian cancer metastasis
Cao, L. (2012) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1779
DDRs in Healthy and Cancerous Reproductive Systems
Marco, M., & Gill, P. R. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6383-6_9
Thibault, B., Thole, A., Basset, C., & Guillermet‐Guibert, J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/777649
Bhatt, A., Parikh, L., Mishra, S. R., & Gléhen, O. (2020) · Springer eBooks · doi:10.1007/978-981-15-3773-8_5
Models of ovarian cancer to test new agents
Sodi, V. L., Craig, A. D., Peri, S., & Connolly, D. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819840-7.00012-1
Ray, U., Roy, D., Jin, L., Thirusangu, P., Staub, J. K., Xiao, Y., Kalogera, E., Hendrickson, A. E. W., Cullen, G. D., Goergen, K. M., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-147840/v1
Cancer Stem Cells in Gynecologic Cancer
Ishiguro, T., & Enomoto, T. (2021) · Current human cell research and applications · doi:10.1007/978-981-33-6013-6_1
Ovarian/Primary Peritoneal Carcinoma
Davidson, B. (2011) · Springer eBooks · doi:10.1007/978-0-85729-697-9_9
Davidson, B. (2018) · Springer eBooks · doi:10.1007/978-3-319-76478-8_9
Mutsaers, S. E., & Herrick, S. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-08-102723-3.00075-5
Thibault, B., Thole, A., Basset, C., & Guillermet‐Guibert, J. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3947352
Zhang, S., Balch, C., Chan, M. W. Y., Lai, H., Matei, D. E., Schilder, J. M., Yan, P. S., Huang, T. H. ‐., & Nephew, K. P. (2023) · doi:10.1158/0008-5472.c.6497228
Data from Targeting LRRC15 Inhibits Metastatic Dissemination of Ovarian Cancer
Ray, U., Jung, D., Jin, L., Xiao, Y., Dasari, S., Bhattacharya, S. S., Thirusangu, P., Staub, J. K., Roy, D., Roy, B., et al. (2023) · doi:10.1158/0008-5472.c.6513550.v1
Engineering Approaches in Ovarian Cancer Cell Culture
Iwanicki, M., Pavlovič, T., & Behboodi, P. (2023) · Current cancer research · doi:10.1007/978-3-031-22802-5_8
Рудіченко, В. М., Khomenko, I. P., Reizin, V. I., Mashchenko, O. I., Reizin, D. V., Sokolenko, A. L., & Torpan, V. V. (2023) · Medicine of Ukraine · doi:10.37987/1997-9894.2023.4-5(270-271).294027
Villagómez, F. R., Lang, J., Núñez-Avellaneda, D., Behbakht, K., Dimmick, H. L., Webb, P. G., Nephew, K. P., Neville, M. C., Woodruff, E. R., & Bitler, B. G. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.04.611120
Ray, U., Roy, D., Jin, L., Thirusangu, P., Staub, J. K., Xiao, Y., Kalogera, E., Wahner-Hendrickson, A. E., Cullen, G. D., Goergen, K. M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14728585
Terri, M., Sandoval, P., Bontempi, G., Montaldo, C., Tomero‐Sanz, H., de Turris, V., Trionfetti, F., Pascual‐Antón, L., Clares, I., Battistelli, C., et al. (2024) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.6084/m9.figshare.25045388
Kumar, R., Jamdade, V., Athare, P., Deshmukh, J., Yadav, N., & Barde, S. (2025) · DMIHER International Conference on Artificial Intelligence in Healthcare, Education and Industry (IDICAIHEI) · doi:10.1109/idicaihei65991.2025.11378279
Bano, N., Browning, J. L., Lewis, I., Amin, M., Zimmerman, P., Lee, L., & Schmelz, E. M. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1744403
Marcus, P., Warrington, J., Zhang, M., Ankathatti-Munegowda, M., Wang, X., Rashedi, I., & Keating, A. (2026) · PLoS ONE · doi:10.1371/journal.pone.0347095
Cancer Stem Cells in Ovarian Cancer
Fang, F., Balch, C., Li, M., Pilrose, J. M., & Nephew, K. P. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-246-5_9
Metadata
- Authors
- Burleson, K. M., Casey, R. C., Skubitz, K. M., Pambuccian, S. E., Oegema, T. R., & Skubitz, A. P. N.
- Affiliations
- University of Minnesota (US)
- Corresponding author
- Skubitz, Amy P.N
- Venue
- Gynecologic Oncology
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 93
- Issue
- 1
- Pages
- 170-181
- ISSN
- 0090-8258 (ISSN-L)
- OpenAlex
- W1996604878
- Cited by
- 269
- References
- 55
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 9 · 2023: 14 · 2022: 11 · 2021: 24 · 2020: 23 · 2019: 12 · 2018: 13 · 2017: 17 · 2016: 13 · 2015: 13 · 2014: 21 · 2013: 18 · 2012: 11
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gynecologic Oncology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Minnesota
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Keywords
- ovarian carcinoma, ascites, tumor spheroids, cell adhesion, extracellular matrix, mesothelial cells, beta1 integrin, fibronectin, collagen, hyaluronic acid, cancer dissemination, peritoneal carcinomatosis
- MeSH terms
- Ascites, Cell Adhesion, Epithelium, Extracellular Matrix, Female, Humans, Hyaluronic Acid, Neoplasm Staging, Ovarian Neoplasms, Peritoneal Cavity, Tumor Cells, Cultured, Extracellular Matrix Proteins, Spheroids, Cellular, Integrin beta1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review